LUNA:VIE
H Lundbeck A/S Class A
€ 7.72
arrow_upward
+1.45%(+0.11) Siku 1
13 Nov, 17:36:00 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya LUNA...
Fungua
€ 7.75
Juu
€ 7.80
Chini
€ 7.55
Mtaji wa soko
58.13B
Wastani wa kiasi cha mauzo
143.00
Kiasi cha mauzo ya hisa
17.00
Juu kwa wiki 52
€ 8.17
Chini kwa wiki 52
€ 4.22
Idadi ya wafanyakazi
elfu 5
Fungua
€ 7.75
Juu
€ 7.80
Chini
€ 7.55
Mtaji wa soko
58.13B
Wastani wa kiasi cha mauzo
143.00
Kiasi cha mauzo ya hisa
17.00
Juu kwa wiki 52
€ 8.17
Chini kwa wiki 52
€ 4.22
Idadi ya wafanyakazi
elfu 5
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
TradingView
·
siku 1 iliyopita
H. Lundbeck Q3 2026 Earnings Call Is Live
Morningstar
·
siku 1 iliyopita
Strong Demand For Vyepti Drives Improved Near-Term Outlook For Lundbeck
GuruFocus
·
siku 1 iliyopita
H. Lundbeck AS (HLUBF) (Q3 2026) Earnings Call Highlights: Raised Guidance and Strong Vyepti Momentum
Investing.com
·
siku 2 zilizopita
Earnings call transcript: Lundbeck lifts 2026 outlook on strong Q3 growth
Wasifu
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
Kuhusu H Lundbeck A/S Class A
Afisa Mkuu Mtendaji (CEO)Charl Van Zyl
Wafanyakazielfu 5
Lilianzishwa1915
Makao makuu-
SektaHealth Care
Sekta-
Tovutilundbeck.com